Skip to content

ThermoSmart® Versus Conventional Humidification in Continuous Positive Airway Pressure (CPAP)

Prospective, Randomized, Double-blind Cross-over Study Comparing ThermoSmart® to Conventional Heated Humidity in Patients Suing Continuous Positive Airway Pressure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00751335
Enrollment
79
Registered
2008-09-11
Start date
2006-08-31
Completion date
2008-10-31
Last updated
2020-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Keywords

Obstructive Sleep Apnea, Humidification, Continuous Positive Airway Pressure

Brief summary

That ThermoSMart humidification will result in greater compliance (mask on time, objective and subjective sleep quality than conventional humidification.

Interventions

DEVICECPAP with ThermoSmart, then CPAP without ThermoSmart

CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube. CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.

DEVICECPAP without ThermoSmart, then CPAP with ThermoSmart

CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube. CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.

Sponsors

Suburban Lung Associates
CollaboratorOTHER
Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ≥ 18 years of age 2. Previous diagnosis of OSA permitted, but patient must be novel to CPAP and no previous surgical intervention for OSA or treatment with an oral appliance. 3. AHI ≥ 15 OR AHI ≥ 5 + ESS ≥ 10 OR ESS ≥ 10 + a medical co-morbidity 4. Patient willing to give informed consent and follow study protocol.

Exclusion criteria

1. Wake resting SpO2 \< 90% 2. Patient requires BiLevel PAP or supplemental oxygen 3. The patient is medically unstable (e.g. respiratory or cardiac failure) 4. Patient unwilling to give informed consent or follow study protocol.

Design outcomes

Primary

MeasureTime frame
CPAP Compliance1, 4 & 8 weeks

Secondary

MeasureTime frame
Subjective & Objective Sleep Parameters1, 4 & 8 weeks

Countries

United States

Participant flow

Recruitment details

All data from this trial has been lost This includes all case report forms and consent forms and therefore, there are no results to report as no data exists

Participants by arm

ArmCount
CPAP With ThermoSmart, Then CPAP Without ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube. CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
0
CPAP Without ThermoSmart, Then CPAP With ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube. CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
0
Total0

Baseline characteristics

Characteristic
Region of Enrollment
United States
— participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

CPAP Compliance

Time frame: 1, 4 & 8 weeks

Population: All data from this trial has been lost This includes all case report forms and consent forms and therefore, there are no results to report as no data exists

Secondary

Subjective & Objective Sleep Parameters

Time frame: 1, 4 & 8 weeks

Population: All data from this trial has been lost. This includes all case report forms and consent forms and therefore, there are no results to report as no data exists

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026